SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026120
Filing Date
2022-12-07
Accepted
2022-12-07 08:34:16
Documents
16
Period of Report
2022-12-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pepg-20221207.htm   iXBRL 8-K 51804
2 EX-99.1 pepg-ex99_1.htm EX-99.1 42013
3 GRAPHIC img148377401_0.jpg GRAPHIC 6751
4 GRAPHIC img148377401_1.jpg GRAPHIC 83110
5 GRAPHIC img148377401_2.jpg GRAPHIC 90005
  Complete submission text file 0000950170-22-026120.txt   464428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pepg-20221207_lab.xml EX-101.LAB 13350
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pepg-20221207.xsd EX-101.SCH 2451
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pepg-20221207_pre.xml EX-101.PRE 9828
10 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20221207_htm.xml XML 4687
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 221449189
SIC: 2834 Pharmaceutical Preparations